GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omnimmune Holdings Inc (GREY:OMMH) » Definitions » Dividends per Share

Omnimmune Holdings (Omnimmune Holdings) Dividends per Share : $0.00 (TTM As of Sep. 2010)


View and export this data going back to 2007. Start your Free Trial

What is Omnimmune Holdings Dividends per Share?

Omnimmune Holdings's dividends per share for the three months ended in Sep. 2010 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2010 was $0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2010 was 0.00. As of today, Omnimmune Holdings's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.


Omnimmune Holdings Dividends per Share Historical Data

The historical data trend for Omnimmune Holdings's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnimmune Holdings Dividends per Share Chart

Omnimmune Holdings Annual Data
Trend May07 May08 Dec09
Dividends per Share
- - -

Omnimmune Holdings Quarterly Data
May07 Aug07 Nov07 Feb08 May08 Aug08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Omnimmune Holdings's Dividends per Share

For the Biotechnology subindustry, Omnimmune Holdings's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnimmune Holdings's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omnimmune Holdings's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Omnimmune Holdings's Dividend Yield % falls into.



Omnimmune Holdings Dividends per Share Calculation

Dividends paid to per common share.


Omnimmune Holdings  (GREY:OMMH) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Omnimmune Holdings's Dividend Payout Ratio for the quarter that ended in Sep. 2010 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2010 )/ EPS without NRI (Q: Sep. 2010 )
=0/ -0.03
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnimmune Holdings Dividends per Share Related Terms

Thank you for viewing the detailed overview of Omnimmune Holdings's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnimmune Holdings (Omnimmune Holdings) Business Description

Traded in Other Exchanges
N/A
Address
4600 Post Oak Place, Suite 352, Houston, TX, USA, 77027
Website
Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Omnimmune Holdings (Omnimmune Holdings) Headlines

No Headlines